319494-39-8

AC-VEID-CHO is a peptide-derived cysteine aspartate-specific protease inhibitor that targets Caspase-6, Casapase-3, and Caspase-7 with IC50 values of 16.2 nM, 13.6 nM, and 162.1 nM, respectively. This compound also inhibits VEIDase activity, showing an IC50 value of 0.49 µM. AC-VEID-CHO is utilized in research concerning neurodegenerative diseases such as Alzheimer's disease and Huntington's disease.

AC-VEID-CHO (TFA) is a peptide-derived inhibitor targeting Caspases-6, -3, and -7, with IC50 values of 16.2 nM, 13.6 nM, and 162.1 nM, respectively. This compound demonstrates significant inhibitory potency and is applicable in the study of neurodegenerative diseases, such as Alzheimer's and Huntington's disease [1].